Transforming STEMI Care: Bridging Interventional and Heart Failure Cardiology to Improve Patient Outcomes
Overview
This engaging session features the collaborative efforts of interventional and heart failure cardiologists in revolutionizing the management of ST-Elevation Myocardial Infarction (STEMI) and its impact on heart failure.
Through a dynamic fireside chat format, our esteemed panelists will explore groundbreaking approaches and advancements that are reshaping STEMI care. They will delve into SuperSaturated Oxygen (SSO2) Therapy as a breakthrough treatment post-PCI that extends beyond the focus of only treating the epicardial vessel and into the microvasculature. Discussions will be centered around SSO2 Therapy’s ability to directly address key predictors of heart failure, including microvascular obstruction/dysfunction, infarct size, adverse left ventricular (LV) remodeling, and LV function.
This broadcast is an essential event for cardiologists seeking to optimize STEMI care and elevate patient outcomes, management strategies, and overall quality of life for STEMI patients. Don't miss this opportunity to gain valuable insights from our esteemed panel and stay at the forefront of advancements in STEMI management.
Learning Objectives
- Gain insights into advancements that are reshaping STEMI care and their implications for optimizing patient outcomes
- Understand the importance of treating beyond the epicardial vessel post-PCI and into the microvasculature
- Learn about the role of SuperSaturated Oxygen Therapy as a breakthrough STEMI treatment post-PCI that addresses key predictors of heart failure, including microvascular obstruction/dysfunction, infarct size, adverse LV remodeling, and LV function
Target Audience
- Interventional Cardiologists
- Cardiologists
- Heart Failure Cardiologists
- Cath Lab Staff
